145 related articles for article (PubMed ID: 11812598)
1. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
Cecil BD
Lancet; 2002 Jan; 359(9302):263-4. PubMed ID: 11812598
[No Abstract] [Full Text] [Related]
2. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
Picon PD; Costa AF; Kuchenbecker R; Beltrame A
Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812597
[No Abstract] [Full Text] [Related]
3. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
Santin M; Shaw E
Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812596
[No Abstract] [Full Text] [Related]
4. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
5. Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases.
Buti M; Valdés A; Sánchez-Avila F; Esteban R; Lurie Y
Hepatology; 2003 May; 37(5):1226-7. PubMed ID: 12717407
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.
Sullivan SD; Jensen DM; Bernstein DE; Hassanein TI; Foster GR; Lee SS; Cheinquer H; Craxi A; Cooksley G; Klaskala W; Pettit K; Patel KK; Green J
Am J Gastroenterol; 2004 Aug; 99(8):1490-6. PubMed ID: 15307866
[TBL] [Abstract][Full Text] [Related]
7. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.
Hassanein T; Cooksley G; Sulkowski M; Smith C; Marinos G; Lai MY; Pastore G; Trejo-Estrada R; Horta E Vale A; Wintfeld N; Green J
J Hepatol; 2004 Apr; 40(4):675-81. PubMed ID: 15030985
[TBL] [Abstract][Full Text] [Related]
8. Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
Henry MJ
N Engl J Med; 2005 Sep; 353(11):1182-3; author reply 1182-3. PubMed ID: 16167381
[No Abstract] [Full Text] [Related]
9. Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
Borg BB; Hoofnagle JH
N Engl J Med; 2005 Sep; 353(11):1182-3; author reply 1182-3. PubMed ID: 16162894
[No Abstract] [Full Text] [Related]
10. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.
Antonini MG; Babudieri S; Maida I; Baiguera C; Zanini B; Fenu L; Dettori G; Manno D; Mura MS; Carosi G; Puoti M
Infection; 2008 Jun; 36(3):250-5. PubMed ID: 18458815
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.
Wirth S; Pieper-Boustani H; Lang T; Ballauff A; Kullmer U; Gerner P; Wintermeyer P; Jenke A
Hepatology; 2005 May; 41(5):1013-8. PubMed ID: 15793840
[TBL] [Abstract][Full Text] [Related]
12. [Peginterferon-alpha and ribavirin combination therapy in chronic hepatitis C].
Han KH; Yoon YH
Korean J Hepatol; 2004 Jun; 10(2):81-7. PubMed ID: 15218341
[No Abstract] [Full Text] [Related]
13. Peginterferon alfa-2a (40KD) (Pegasys) for the treatment of patients with chronic hepatitis C.
Ferenci P
Int J Clin Pract; 2003 Sep; 57(7):610-5. PubMed ID: 14529063
[TBL] [Abstract][Full Text] [Related]
14. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence.
Hrachovec J; Patel P
Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198
[No Abstract] [Full Text] [Related]
15. Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.
Bruno S; Cammà C; Di Marco V; Rumi M; Vinci M; Camozzi M; Rebucci C; Di Bona D; Colombo M; Craxì A; Mondelli MU; Pinzello G
J Hepatol; 2004 Sep; 41(3):474-81. PubMed ID: 15336451
[TBL] [Abstract][Full Text] [Related]
16. Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
Crespo M; Sauleda S; Esteban JI; Juarez A; Ribera E; Andreu AL; Falco V; Quer J; Ocaña I; Ruiz I; Buti M; Pahissa A; Esteban R; Guardia J
J Viral Hepat; 2007 Apr; 14(4):228-38. PubMed ID: 17381714
[TBL] [Abstract][Full Text] [Related]
17. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
Lo Nigro L; La Spina M; Mirabile E; Pisana P; Schilirò G; Guardo P
Pediatr Blood Cancer; 2004 Aug; 43(2):185. PubMed ID: 15236293
[No Abstract] [Full Text] [Related]
18. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
[TBL] [Abstract][Full Text] [Related]
19. [Peginterferon alfa-2a plus ribavirin for initial treatment of chronic hepatitis C in Korea].
Lee H; Choi MS; Paik SW; Kim JH; Kim DY; Lee JH; Koh KC; Yoo BC; Rhee JC; Song SM
Korean J Hepatol; 2006 Mar; 12(1):31-40. PubMed ID: 16565604
[TBL] [Abstract][Full Text] [Related]
20. [Peginterferon alfa-2b and ribavirin-induced pure red cell aplasia during treatment of chronic hepatitis C treated by cyclosporin A with good response].
Kato M; Ryu T; Miura H; Yamada H; Saito T
Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1678-80. PubMed ID: 18681159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
